Annual ROE
-35.24%
-23.80%-208.04%
December 31, 2023
Summary
- As of February 8, 2025, CODX annual return on equity is -35.24%, with the most recent change of -23.80% (-208.04%) on December 31, 2023.
- During the last 3 years, CODX annual ROE has fallen by -159.38% (-128.39%).
- CODX annual ROE is now -119.79% below its all-time high of 178.07%, reached on December 31, 2015.
Performance
CODX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-51.60%
-8.88%-20.79%
September 30, 2024
Summary
- As of February 8, 2025, CODX quarterly return on equity is -51.60%, with the most recent change of -8.88% (-20.79%) on September 30, 2024.
- Over the past year, CODX quarterly ROE has dropped by -17.24% (-50.17%).
- CODX quarterly ROE is now -112.72% below its all-time high of 405.72%, reached on September 30, 2017.
Performance
CODX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CODX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -208.0% | -50.2% |
| 3 y3 years | -128.4% | -50.2% |
| 5 y5 years | +92.2% | -50.2% |
CODX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -196.7% | at low | -230.9% | at low |
| 5 y | 5-year | -128.4% | +98.1% | -140.8% | +76.0% |
| alltime | all time | -119.8% | +98.1% | -112.7% | +98.2% |
Co-Diagnostics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -51.60%(+20.8%) |
| Jun 2024 | - | -42.72%(+5.0%) |
| Mar 2024 | - | -40.69%(+18.4%) |
| Dec 2023 | -35.24%(+208.0%) | -34.36%(-9.1%) |
| Sep 2023 | - | -37.80%(+21.2%) |
| Jun 2023 | - | -31.20%(+28.3%) |
| Mar 2023 | - | -24.31%(+130.9%) |
| Dec 2022 | -11.44%(-131.4%) | -10.53%(-191.9%) |
| Sep 2022 | - | 11.46%(-49.7%) |
| Jun 2022 | - | 22.80%(-38.5%) |
| Mar 2022 | - | 37.07%(-6.0%) |
| Dec 2021 | 36.45%(-70.6%) | 39.43%(-28.0%) |
| Sep 2021 | - | 54.77%(-25.0%) |
| Jun 2021 | - | 73.06%(-29.5%) |
| Mar 2021 | - | 103.61%(-15.2%) |
| Dec 2020 | 124.14% | 122.25%(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | 126.56%(+51.0%) |
| Jun 2020 | - | 83.79%(-198.4%) |
| Mar 2020 | - | -85.13%(-60.5%) |
| Dec 2019 | -1826.40%(+306.5%) | -215.39%(-14.1%) |
| Sep 2019 | - | -250.89%(-15.0%) |
| Jun 2019 | - | -295.01%(-21.3%) |
| Mar 2019 | - | -374.96%(-19.6%) |
| Dec 2018 | -449.31%(-72.4%) | -466.13%(+107.5%) |
| Sep 2018 | - | -224.60%(-53.0%) |
| Jun 2018 | - | -478.01%(-55.6%) |
| Mar 2018 | - | -1075.82%(-63.3%) |
| Dec 2017 | -1626.11%(-2624.6%) | -2930.19%(-822.2%) |
| Sep 2017 | - | 405.72%(+491.1%) |
| Jun 2017 | - | 68.64%(+8.1%) |
| Mar 2017 | - | 63.50%(-45.1%) |
| Dec 2016 | 64.41%(-63.8%) | 115.57% |
| Dec 2015 | 178.07% | - |
FAQ
- What is Co-Diagnostics annual return on equity?
- What is the all time high annual ROE for Co-Diagnostics?
- What is Co-Diagnostics annual ROE year-on-year change?
- What is Co-Diagnostics quarterly return on equity?
- What is the all time high quarterly ROE for Co-Diagnostics?
- What is Co-Diagnostics quarterly ROE year-on-year change?
What is Co-Diagnostics annual return on equity?
The current annual ROE of CODX is -35.24%
What is the all time high annual ROE for Co-Diagnostics?
Co-Diagnostics all-time high annual return on equity is 178.07%
What is Co-Diagnostics annual ROE year-on-year change?
Over the past year, CODX annual return on equity has changed by -23.80% (-208.04%)
What is Co-Diagnostics quarterly return on equity?
The current quarterly ROE of CODX is -51.60%
What is the all time high quarterly ROE for Co-Diagnostics?
Co-Diagnostics all-time high quarterly return on equity is 405.72%
What is Co-Diagnostics quarterly ROE year-on-year change?
Over the past year, CODX quarterly return on equity has changed by -17.24% (-50.17%)